TrialJournal of cardiac failure2023

The Cardiorenal Effects of Chronic Phosphodiesterase-V Inhibition in Preclinical Diastolic Dysfunction (Stage B Heart Failure).

Shravya Vinnakota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.